Korea to Strengthen Support for Rare Disease Patients
This week, the Korean Ministry of Food and Drug Safety announced that it would enhance drug safety management and make a new, streamlined review process for advanced healthcare goods. The…
Patrick is the managing editor of PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
This week, the Korean Ministry of Food and Drug Safety announced that it would enhance drug safety management and make a new, streamlined review process for advanced healthcare goods. The…
PharmaBoardroom’s list of personalities whose voices, opinions and decisions matter in Canadian pharma’s industry, regulatory affairs, reimbursement and pricing. The Honourable Ginette Petitpas Taylor Minister of Health The…
Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and…
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease…
The administration of President Moon Jae-in is moving to ensure the enduring success of South Korea’s healthcare and life sciences industries through increased international collaboration. However, some pharma insiders are…
It was less than a decade ago (2011) that Samsung Biologics was a new kid on the block amongst Korea’s booming biotech conglomerates. Since then the company has snowballed, building…
China is set to become the second largest market for Mundipharma’s OxyContin behind the US. It comes as no surprise that sales of opioids such as OxyContin have plummeted…
Against an alluring backdrop, big-name pharma brands are now starting to spend heavily on in-country manufacturing, development and shared service facilities in Spain. Spain has exceedingly high youth unemployment.…
As the 3rd largest pharma region in Asia, Korea’s booming pharma industry owes much to its mass of family-run conglomerates known as Chaebol. It comes as no surprise to find tech…
An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of medical research. According to the Association of Medical Research Charities (AMRC), in 2017, 8 million people…
Indian pharma companies provide affordable generic drugs to patients in almost all countries across the globe, hence the reason India has been dubbed ‘ the pharmacy to the world.’ Furthermore,…
Last week, Bristol-Myers Squibb (BMS) announced that they have entered into a definitive merger agreement under which Bristol-Myers Squibb will acquire Celgene in a cash and stock transaction with an…
See our Cookie Privacy Policy Here
